The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative effectiveness of linvoseltamab versus standard-of-care (SOC) treatment (tx) in real-world patients (pts) in the United States (US) with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM).
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); K36 (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MedImmune (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Pfizer
 
Katja C Weisel
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; GlaxoSmithKline; Janssen (Inst); Janssen-Cilag; Karyopharm Therapeutics; Menarini; Novartis; Oncopeptides; Pfizer; Roche; Sanofi; Stemline Therapeutics; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Menarini; Oncopeptides; Roche; Sanofi; Takeda
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen-Cilag; Menarini; Takeda
 
Qiufei Ma
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Christian Hampp
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Olivier Humblet
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Mostafa Shokoohi
Employment - EVERSANA
Consulting or Advisory Role - EVERSANA
 
Nicolle Bonar
Employment - EVERSANA
Consulting or Advisory Role - EVERSANA
 
Paul Spin
Employment - EVERSANA
Consulting or Advisory Role - Nicolle Bonar
 
James Harnett
Employment - Regeneron
Stock and Other Ownership Interests - Pfizer; Regeneron
 
Wenzhen Ge
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Jessica J Jalbert
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Rachel E Sobel
Employment - Regeneron
Leadership - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Glenn Scott Kroog
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Research Funding - Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Karen Rodriguez-Lorenc
Employment - Regeneron
Stock and Other Ownership Interests - Novartis; Regeneron
 
Sundar Jagannath
Consulting or Advisory Role - Bristol-Myers Squibb; Caribou Biosciences; Janssen; Karyopharm Therapeutics; Legend Biotech; Regeneron; Sanofi; Takeda
Travel, Accommodations, Expenses - Brystol-Myers Squibb; Janssen Biotech